Discovering chemical modifiers of oncogene-regulated hematopoietic differentiation

被引:116
作者
Yeh, Jing-Ruey J. [1 ,2 ,3 ]
Munson, Kathleen M. [1 ,2 ,3 ]
Elagib, Kamaleldin E. [4 ]
Goldfarb, Adam N. [4 ]
Sweetser, David A. [2 ,5 ]
Peterson, Randall T. [1 ,2 ,3 ]
机构
[1] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dev Biol Lab, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
[3] MIT & Harvard, Broad Inst, Cambridge Ctr 7, Cambridge, MA 02142 USA
[4] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA
[5] Massachusetts Gen Hosp, Div Pediat Hematol Oncol, Dept Pediat, Boston, MA 02114 USA
关键词
ACUTE MYELOID-LEUKEMIA; GLYCOGEN-SYNTHASE KINASE-3; PROSTAGLANDIN E-2; VALPROIC ACID; INTESTINAL POLYPOSIS; PROGENITOR CELLS; GENE DISRUPTION; KNOCKOUT MICE; BETA-CATENIN; COLON-CANCER;
D O I
10.1038/nchembio.147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
It has been proposed that inhibitors of an oncogene's effects on multipotent hematopoietic progenitor cell differentiation may change the properties of the leukemic stem cells and complement the clinical use of cytotoxic drugs. Using zebrafish, we developed a robust in vivo hematopoietic differentiation assay that reflects the activity of the oncogene AML1-ETO. Screening for modifiers of AML1-ETO-mediated hematopoietic dysregulation uncovered unexpected roles of COX-2- and beta-catenin-dependent pathways in AML1-ETO function. This approach may open doors for developing therapeutics targeting oncogene function within leukemic stem cells.
引用
收藏
页码:236 / 243
页数:8
相关论文
共 50 条
[1]   Myelopoiesis in the zebrafish, Danio rerio [J].
Bennett, CM ;
Kanki, JP ;
Rhodes, J ;
Liu, TX ;
Paw, BH ;
Kieran, MW ;
Langenau, DM ;
Delahaye-Brown, A ;
Zon, LI ;
Fleming, MD ;
Look, AT .
BLOOD, 2001, 98 (03) :643-651
[2]   Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia [J].
Bug, Gesine ;
Schwarz, Kerstin ;
Schoch, Claudia ;
Kampfmann, Manuela ;
Henschler, Reinhard ;
Hoelzer, Dieter ;
Ottmann, Oliver G. ;
Ruthardt, Martin .
HAEMATOLOGICA, 2007, 92 (04) :542-545
[3]   Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis [J].
Castellone, MD ;
Teramoto, H ;
Williams, BO ;
Druey, KM ;
Gutkind, JS .
SCIENCE, 2005, 310 (5753) :1504-1510
[4]   Cyclooxygenase-1-derived PGE2 promotes cell motility via the G-protein-coupled EP4 receptor during vertebrate gastrulation [J].
Cha, YI ;
Kim, SH ;
Sepich, D ;
Buchanan, FG ;
Solnica-Krezel, L ;
DuBois, RN .
GENES & DEVELOPMENT, 2006, 20 (01) :77-86
[5]   Cyclooxygenase-1 signaling is required for vascular tube formation during development [J].
Cha, YI ;
Kim, SH ;
Solnica-Krezel, L ;
DuBois, RN .
DEVELOPMENTAL BIOLOGY, 2005, 282 (01) :274-283
[6]   NSAIDs and cancer prevention: Targets downstream of COX-2 [J].
Cha, Yong I. ;
DuBois, Raymond N. .
ANNUAL REVIEW OF MEDICINE, 2007, 58 :239-252
[7]   Erythroid inhibition by the leukemic fusion AML1-ETO is associated with impaired acetylation of the major erythroid transcription factor GATA-1 [J].
Choi, YJ ;
Elagib, KE ;
Delehanty, LL ;
Goldfarb, AN .
CANCER RESEARCH, 2006, 66 (06) :2990-2996
[8]   β-catenin is dispensable for hematopoiesis and lymphopoiesis [J].
Cobas, M ;
Wilson, A ;
Ernst, B ;
Mancini, JC ;
MacDonald, HR ;
Kemler, R ;
Radtke, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (02) :221-229
[9]   Hematopoietic stem cell expansion and distinct myeloid developmental abnormalities in a murine model of the AML1-ETO translocation [J].
de Guzman, CG ;
Warren, AJ ;
Zhang, Z ;
Gartland, L ;
Erickson, P ;
Drabkin, H ;
Hiebert, SW ;
Klug, CA .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (15) :5506-5517
[10]   RENAL ABNORMALITIES AND AN ALTERED INFLAMMATORY RESPONSE IN MICE LACKING CYCLOOXYGENASE-II [J].
DINCHUK, JE ;
CAR, BD ;
FOCHT, RJ ;
JOHNSTON, JJ ;
JAFFEE, BD ;
COVINGTON, MB ;
CONTEL, NR ;
ENG, VM ;
COLLINS, RJ ;
CZERNIAK, PM ;
GORRY, SA ;
TRZASKOS, JM .
NATURE, 1995, 378 (6555) :406-409